{{Rsnum
|rsid=11110912
|Gene=MYBPC1
|Chromosome=12
|position=101648435
|Orientation=plus
|GMAF=0.1061
|Gene_s=LOC100505814,MYBPC1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 61.1 | 35.4 | 3.5
| HCB | 81.0 | 19.0 | 0.0
| JPT | 79.6 | 20.4 | 0.0
| YRI | 91.1 | 8.9 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 81.0 | 19.0 | 0.0
| CHD | 80.7 | 19.3 | 0.0
| GIH | 66.3 | 28.7 | 5.0
| LWK | 87.3 | 12.7 | 0.0
| MEX | 84.5 | 15.5 | 0.0
| MKK | 63.5 | 32.1 | 4.5
| TSI | 70.3 | 22.8 | 6.9
| HapMapRevision=28
}}[[rs11110912]] has been reported in a large study to be associated with [[high blood pressure]].

The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with heterozygotes is 1.33 (CI 1.18-1.51), and for homozygotes, 1.34 (CI 0.96-1.86). {{PMID|17554300|OA=1
}}

{{PMID Auto
|PMID=18523456
|Title=Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}